
Biocon Limited has informed the Exchange regarding a press release dated May 13, 2024, titled "Biocon Limited signs semi-exclusive distribution and supply deal for the commercialization of generic Saxenda�� (Liraglutide) in Mexico with Medix".
Filed with NSE ·

Biocon Limited has informed the Exchange regarding a press release dated May 13, 2024, titled "Biocon Limited signs semi-exclusive distribution and supply deal for the commercialization of generic Saxenda�� (Liraglutide) in Mexico with Medix".
6ix hasn’t read this filing yet.
Follow Biocon into a list and get an email when it puts out news.
Follow Biocon